Ultimovacs ASA: Mandatory notification of trade by primary insider
Oslo, 29 November 2022, a closely related party of Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs ASA, has today bought 1,500 shares in the company at an average price of NOK 96.7058 per share. Following this transaction, Carlos de Sousa and closely related parties hold 21,556 shares and 416,035 share options in Ultimovacs ASA.
This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act.
Upcoming Life Sciences Events
- November 2023
- Biotechgate Digital Partnering November 2023
- December 2023
- Pharma-Biotech Product & Company Valuation with Dr. P Frei
- Leiden: Dutch Life Sciences Conference
Latest company news
There are currently no news available for this portal